|
Volumn 37, Issue 3, 2015, Pages 459-461
|
Is there an association of hepatitis B virus infection with minimal change disease of nephrotic syndrome? A clinical observational report
|
Author keywords
Glomerulonephritis; HBV DNA nephrotic syndrome; Hepatitis B virus infection; Minimal change disease
|
Indexed keywords
LAMIVUDINE;
METHYLPREDNISOLONE;
TELBIVUDINE;
ANTIVIRUS AGENT;
IMMUNOSUPPRESSIVE AGENT;
THYMIDINE;
ADULT;
ARTICLE;
CASE REPORT;
DISEASE ASSOCIATION;
FEMALE;
GENERAL ASPECTS OF DISEASE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY BIOPSY;
KIDNEY PARENCHYMA;
MALE;
MINIMAL CHANGE DISEASE;
NEPHROTIC SYNDROME;
OBSERVATIONAL STUDY;
PRIORITY JOURNAL;
STAINING;
YOUNG ADULT;
ANALOGS AND DERIVATIVES;
BIOPSY;
COMPLICATION;
DRUG COMBINATION;
DRUG EFFECTS;
DRUG MONITORING;
GLOMERULUS;
HEPATITIS B, CHRONIC;
ISOLATION AND PURIFICATION;
KIDNEY FUNCTION TEST;
NEPHROSIS, LIPOID;
PATHOLOGY;
PATHOPHYSIOLOGY;
TREATMENT OUTCOME;
ADULT;
ANTIVIRAL AGENTS;
BIOPSY;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FUNCTION TESTS;
KIDNEY GLOMERULUS;
LAMIVUDINE;
MALE;
METHYLPREDNISOLONE;
NEPHROSIS, LIPOID;
THYMIDINE;
TREATMENT OUTCOME;
|
EID: 84929071597
PISSN: 0886022X
EISSN: 15256049
Source Type: Journal
DOI: 10.3109/0886022X.2014.1001711 Document Type: Article |
Times cited : (9)
|
References (4)
|